Skip to Main Content

Author Details

Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
1974
246
61
PMIDPaper TitleJournal TitlePublished Year
36566990The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice.Radiother Oncol2023
37150445Are hybrid conferences the new standard?Radiother Oncol2023
34597718Brachial Plexus Tolerance to Single-Session SABR in a Pig Model.Int J Radiat Oncol Biol Phys2022
35427552In Reply to Goyal and Madan.Int J Radiat Oncol Biol Phys2022
35051440Personalised radiation therapy taking both the tumour and patient into consideration.Radiother Oncol2022
33387585Radiation oncology in the new virtual and digital era.Radiother Oncol2021
34195490In Silico Single-Fraction Stereotactic Ablative Radiation Therapy for the Treatment of Thoracic and Abdominal Oligometastatic Disease With Online Adaptive Magnetic Resonance Guidance.Adv Radiat Oncol2021
31953062Existence of a Dose-Length Effect in Spinal Nerves Receiving Single-Session Stereotactic Ablative Radiation Therapy.Int J Radiat Oncol Biol Phys2020
30953713Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy.Int J Radiat Oncol Biol Phys2019
29873307Corrigendum: Potential role of the glycolytic oscillator in acute hypoxia in tumors (2015 <i>Phys. Med. Biol.</i> 60 9215).Phys Med Biol2018
28333004Obituary and Tribute to John "Jack" Francis Fowler, PhD, DSc (1925-2016).Int J Radiat Oncol Biol Phys2017
27128739Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.Radiat Res2016
24347430Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.Head Neck2015
26576743Potential role of the glycolytic oscillator in acute hypoxia in tumors.Phys Med Biol2015
26141946Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers.Mol Cancer Ther2015
24668936Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.Head Neck2014
24571588Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.BMC Cancer2014
22985780Spinal cord tolerance to single-session uniform irradiation in pigs: implications for a dose-volume effect.Radiother Oncol2013
24061351On the importance of prompt oxygen changes for hypofractionated radiation treatments.Phys Med Biol2013
24060168Paralysis following stereotactic spinal irradiation in pigs suggests a tolerance constraint for single-session irradiation of the spinal nerve.Radiother Oncol2013
24059677EGFR-inhibition enhances apoptosis in irradiated human head and neck xenograft tumors independent of effects on DNA repair.Radiat Res2013
24192080Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.Mol Cancer2013
24183263Molecular radiation biology/oncology at its best: cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology.Radiother Oncol2013
23891100The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response.Radiother Oncol2013
23908684Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.Transl Oncol2013
23849692Evaluation and immunohistochemical qualification of carbogen-induced οR2 as a noninvasive imaging biomarker of improved tumor oxygenation.Int J Radiat Oncol Biol Phys2013
23867129Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.Eur J Cancer2013
23998444Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.Discov Med2013
23719582Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.Radiother Oncol2013
23471998PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS.Proc Natl Acad Sci U S A2013
23453541Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models.Radiother Oncol2013
22197239Spinal cord tolerance to reirradiation with single-fraction radiosurgery: a swine model.Int J Radiat Oncol Biol Phys2012
28519053SU-E-T-06: A Mathematical Explanation to Tumor's Response to Perfusion and Hypoxic Fraction after Radiation.Med Phys2012
28519036SU-E-J-196: In-Vivo Tumor Blood-Oxygen Content Measurement via Interstitial Optical Transmission Spectroscopy.Med Phys2012
28519022SU-E-J-197: A Novel Optical Interstitial Fiber Spectroscopic System for Real-Time Tissue Micro-Vascular Hemodynamics Monitoring.Med Phys2012
23046567Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.BMC Cancer2012
23157980Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units.Radiother Oncol2012
22704363(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.Radiat Oncol2012
22508814Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.J Clin Oncol2012
22621752Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.Radiat Oncol2012
20934278Spinal cord tolerance to single-fraction partial-volume irradiation: a swine model.Int J Radiat Oncol Biol Phys2011
21775008Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.Radiother Oncol2011
21843774Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.Nucl Med Biol2011
21873245Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.Proc Natl Acad Sci U S A2011
21569415Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.BMC Cancer2011
21665307Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction.Radiother Oncol2011
21684617Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients.Radiother Oncol2011
21302028Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers.Cell Oncol (Dordr)2011
20009000Innovations in radiotherapy planning of head and neck cancers: role of PET.J Nucl Med2010
20927320Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions.Neoplasia2010
  • 1 - 50 of 246

Recommended Authors

University Medical Center Utrecht
Career Start Year 2005
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 1
University of California san francisco
Career Start Year 1998
Number of shared co-authors 2
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1997
Number of shared co-authors 2
MSC National Research Institute of Oncology Gliwice Branch
Career Start Year 1996
Number of shared co-authors 1
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 1991
Number of shared co-authors 2
Switzerland Ecole Polytechnique Federal de Lausanne, EPFL
Career Start Year 1991
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 1
Medical University of Vienna
Career Start Year 1987
Number of shared co-authors 2
University of Antwerp
Career Start Year 1987
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 6
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 1
Medical Center, University of Freiburg
Career Start Year 1984
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Manchester
Career Start Year 1981
Number of shared co-authors 7
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 1
Laval University, CHU de Quebec
Career Start Year 1980
Number of shared co-authors 1
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 1
Henry Ford Hospital
Career Start Year 1973
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1968
Number of shared co-authors 4
Stanford University School of Medicine
Career Start Year 1968
Number of shared co-authors 3
Mount Sinai Hospital
Career Start Year 1943
Number of shared co-authors 1

Collaborators

Radboud University Medical Center
Co-authored papers 67
Radboud University, Nijmegen Medical Centre
Co-authored papers 66
Radboud University Medical Center
Co-authored papers 13
Cancer Center Amsterdam
Co-authored papers 8
Maastricht University
Co-authored papers 7
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
German Cancer Research Center (DKFZ)
Co-authored papers 6
Maastricht University
Co-authored papers 6
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 5
Radboud University Medical Center
Co-authored papers 4
Princess Margaret Cancer Centre University Health Network
Co-authored papers 4
Universita Cattolica del Sacro Cuore
Co-authored papers 3
The Netherlands Cancer Institute
Co-authored papers 3
Radboud University Medical Centre
Co-authored papers 3
Mount Vernon Cancer Centre
Co-authored papers 3
Co-authored papers 2
Maastricht University Medical Center
Co-authored papers 2
University of Oxford
Co-authored papers 2
Maastricht University
Co-authored papers 2
Maastricht University
Co-authored papers 2
Radboud University Medical Center
Co-authored papers 1
Radiumhospitalet, Oslo University Hosptial
Co-authored papers 1
University of Wisconsin-Madison
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Ludwig Institute for Cancer Research
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of Wisconsin School of Medicine and Public Health
Co-authored papers 1
Duke University Medical Center
Co-authored papers 1